Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir

Clinical trial NCT02345707 · COMPLETED

Trial details

NCT number: NCT02345707
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2015-03-01
Primary completion: 2015-06-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.